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MATERIALS AND METHODS  (22)
 
Animals 
PU.1-GFP mice were obtained from the Walter and Eliza Hall Institute, crossed to B6 mice to separate 
the PU.1-GFP locus from the tamoxifen-inducible Cre transgene present in the parental strain, and bred 
and maintained in the Caltech Laboratory Animal Facility.  E13.5 fetuses were obtained by timed-mating 
of PU.1-GFP mice.  All animal protocols were reviewed and approved by the Institute Animal Care and 
Use Committee of the California Institute of Technology. 
Constructs and Reagents 
An internal ribosome entry site (IRES)-mCherry fluorescent protein cassette and an IRES-Histone-2B-
mCerulean CFP fluorescent protein cassette were generated using PCR cloning and inserted into an 
NGFR derivative of the pMIGR1 retroviral vector kindly provided by Lanwei Xu and Warren Pear (Univ. 
Pennsylvania).  Sequences encoding p21, p27, full length PU.1 or the PU.1-ets DNA binding domain 
(amino acids 159-262) were then cloned by PCR and inserted into these empty vector constructs 
upstream of the IRES using the restriction enzymes BglII and EcoRI (New England Biolabs).  A list of 
constructs used for this study is provided in Table S2.  The small molecule CDK4/6 inhibitor PD0332991 
(Selleck Chemicals, Houston, TX) was added to culture medium at a concentration of 2.1 ?M in 0.02% 
DMSO.  The same concentration of DMSO added in the absence of inhibitor did not affect our 
experiments (data not shown). 
Retroviral transduction 
Viral particles were generated by transient co-transfection of the Phoenix-Eco packaging cell line with 
the retroviral construct and the pCL-Eco plasmid (Imgenex, San Diego, CA).  Viral supernatants were 
harvested at two and three days after transfection, and immediately frozen at -80oC until use.  For 
retroviral transduction, tissue culture plates (Costar, Corning) were incubated overnight with 
33 ?g/mL retronectin (Clontech), and then loaded with viral supernatant.  Cells were then cultured 
directly on virus-bound plates under the conditions described below. 
Purification and sorting of fetal liver progenitors 
Purification of fetal liver progenitors from PU.1-GFP mice was performed as previously described (35) .  
Briefly, E13.5 fetal livers were dissected from the fetuses of pregnant mice.  Single-cell suspensions of 
fetal liver cells were then prepared, stained for lineage markers using biotin-conjugated lineage 
antibodies (Ter119, F4/80, Gr-1, CD11c, NK1.1, CD19), incubated with streptavidin-coated magnetic 
beads (Miltenyi Biotec), and passed through a magnetic column (Miltenyi Biotec).  Lineage-depleted 
(Lin-) cells were eluted and stored in liquid nitrogen in freezing media (50% FBS, 40% ?MEM, 10% 
DMSO) for future use.  We did not observe any significant differences between fresh and previously-
frozen Lin- cells with respect to their in vitro differentiation behavior.  Frozen lineage-depleted fetal liver 
cells were either thawed and sorted immediately (Fig. S1, S2, S3, S10), or pre-cultured and concurrently 
infected with different retroviral constructs for two days prior to sorting (Fig. 1, 2, 3, S4, S5, S6, S7, S9, 
S12, S13, S14).  Pre-culture/infection was performed on virus-bound plates (see above) using standard 
culture medium [80% ?MEM (Gibco), 20% HyClone Fetal Bovine Serum (Thermo Scientific), Pen Strep 
Glutamine (Gibco), 50 ?M ?-Mercaptoethanol (Sigma)] supplemented with 5 ng/mL SCF, 5 ng/mL IL-7 
and 5 ng/mL Flt3L (Table S3).  Cells were then stained with cKit, CD27, a biotin-conjugated lineage 
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cocktail (Ter119, F4/80, Gr-1, CD11c, NK1.1, CD19), dye-conjugated-Streptavidin, and 7-
aminoactinomycin D (7AAD, for some experiments, see Table S1), and were then sorted for fetal liver 
progenitors, defined as Lin- 7AAD- (when used) cKit+ CD27+PU.1-GFP-intermediate cells (Fig. S1).  For 
some experiments (Fig. 2C-D, 3E, S5 and S12), this FLP population was further fractionated using the 
surface marker Fc?R2/3.  Cells transduced with retroviral constructs were sorted as mCherry+ cells to 
obtain infected fetal liver progenitors.  For downstream culture experiments, the following populations 
were used:  freshly-thawed and sorted FLPs (Fig. S1, S2, S3, S10); pre-cultured FLPs that were not 
infected (Fig. 1B-C, S4, S6); pre-cultured FLPs infected with MSCV-IRES-mCherry (Fig. 1D-H, 2, 3, S5, S7, 
S9, S12, S13, S14); pre-cultured FLPs infected with MSCV-PU.1-IRES-mCherry (Fig. 3, S13, S14); or pre-
cultured FLPs infected with MSCV-PU.1-ets-IRES-mCherry (Fig. 2, S12).  For experiments in Fig. 2B and 
S10, transduction of p21 and p27 was performed after sorting, by culturing on virus-bound plates.  For 
imaging experiments, retrovirally-expressed mCherry served as a cell marker used for cell segmentation 
and tracking.  For experiments using the CellTrace Violet cell proliferation dye (Invitrogen), sorted cells 
were then incubated with 5 ?M CellTrace Violet at 37oC for 10 minutes prior to culture.  We note that 
fetal liver progenitors (Lin-cKit+CD27+) were chosen for these experiments as they express PU.1-GFP at 
uniform intermediate levels (Fig. 1, Fig. S1), rapidly differentiate into either B- or myeloid cells in vitro 
(35), and form B- or myeloid progeny with comparable frequencies in single-cell cloning experiments 
(Fig. S2). 
Cell culture 
Sorted FLPs were cultured either on tissue-culture treated plates (Costar, Corning) or on glass-bottom 
plates for imaging (Mattek, Ashland, MA).  For imaging experiments (Fig. 1C-H, Fig. 3B-D), glass-bottom 
96-well plates were coated with retronectin (40 ?g/mL, Clontech) to promote cell adhesion.  Cultured 
cells for imaging were plated at a density of 1200-1800 / well.  This density was chosen to maximize the 
starting number of imaged cells (~20-30) while maintaining the culture at low enough cell densities for 
single-cells to be resolved continuously for four days.  For experiments where sorted FLPs were 
subsequently transduced with retroviral constructs, cells were cultured directly on virus-bound plates, 
prepared as described above.   Unless otherwise indicated, cells were cultured in standard medium [80% 
?MEM (Gibco), 20% HyClone Fetal Bovine Serum (Thermo Scientific), Pen Strep Glutamine (Gibco), 50 
?M ?-Mercaptoethanol (Sigma)] supplemented with 5 ng/mL SCF, 0.1 ng/mL IL-3, 5 ng/mL IL-7 and 5 
ng/mL Flt3L (Table S3), except for experiments shown in Figs. 1, S4, S6, where 0.5 ng/mL or 5 ng/mL M-
CSF was also added to promote macrophage differentiation.  The low IL-3 concentrations used here 
facilitated survival of progenitors without excessively suppressing differentiation into the B-cell lineage 
(Fig. S2). 
Flow cytometry of cultured cells 
For flow cytometric analysis, cultured cells were then disaggregated, re-suspended in Fc blocking 
supernatant (2.4G2 hybridoma supernatant, prepared in the Rothenberg lab), then stained using the 
indicated antibodies (Table S1).  Stained samples were then re-suspended, filtered through a nylon mesh 
to remove clumps, and analyzed using either a MacsQuant flow cytometer, or a MacsQuant VYB flow 
cytometer for mCherry-containing samples (Miltenyi Biotec, Auburn, CA).  Acquired flow cytometry data 
was then analyzed using FlowJo flow cytometry analysis software (Tree Star Inc., Ashland, OR). 
Timelapse imaging 
Timelapse imaging of cultured cells was performed on a motorized inverted fluorescence microscope 
(IX-81, Olympus) using a 60x 1.4 NA oil objective (Fig. S7A).  The microscope was fitted with laser-based 
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focus drift correction (ZDC, Olympus) to maintain a constant plane of imaging, and also fitted with a 
custom-built incubator to maintain a constant humidified environment at 37oC with 7% CO2.  Images of 
cultured cells were acquired at fixed time intervals in the differential interference contrast (DIC) 
brightfield channel, and GFP and mCherry fluorescence channels using image acquisition software 
(Metamorph, Molecular Devices).  Shorter timelapse intervals (3 minutes) were used for acquisition of 
DIC images to facilitate cell tracking, whereas longer timelapse intervals (15 minutes) were used for 
acquisition of GFP and mCherry images to minimize photo-toxicity and photo-bleaching.  For each time 
point, images of overlapping adjacent fields of view were acquired by moving a motorized stage (Applied 
Scientific Instrumentation, Eugene, OR) in order to generate a larger tiled image of the cell culture (Fig. 1 
– one 5 x 5 tile; Fig. 3 – two 4 x 4 tiles of different culture wells corresponding to EV and PU.1-
transduced progenitors).  This image tiling was performed so that the cells, which moved rapidly in 
culture, could be tracked for longer periods of time before escaping observation.   Timelapse imaging 
was performed continuously for four days. 
In order to generate the correction matrix for uneven fluorescence illumination (Fig. S7B), tiled images 
of uniformly fluorescent beads (Tetraspeck beads, Invitrogen) were acquired in the same fluorescence 
channels as those used for imaging at the same magnification.  Images were then processed as 
described below. 
Cell segmentation and tracking 
Cell segmentation and tracking was performed using conventional algorithms and procedures for 
analysis of timelapse fluorescence images of living cells [for a review, see (36)].  These algorithms were 
implemented using custom-written code in MATLAB (Mathworks, Natick, MA) following this workflow: 
(I) Fluorescence image background-subtraction and illumination-correction. 
Background grayscale values were subtracted from each fluorescence image using a top-hat 
transform using a disk-shaped structuring element with radius larger than that of a cell.  
Background-subtracted images were then divided by the correction matrix for the same 
fluorescence channel.  To generate the correction matrix, images of fluorescent beads were 
background-subtracted using the top-hat transform, and segmented by thresholding using Otsu’s 
method.  The integrated grayscale intensities, along with x and y coordinate positions for all 
segmented beads were then used to fit a second-degree polynomial surface (Fig. S7B).  Interpolated 
values of this surface at pixel locations were then used for the correction matrix.   
 
(II) Automatic cell segmentation using an edge-detection based method 
Cells were segmented an image processing routine that combines edge detection of cell boundaries 
with morphological image processing routines to correct for segmented image defects (37).   
Corrected mCherry fluorescence images were smoothed using a Gaussian filter, then transformed 
using a 2-dimensional Laplacian filter to generate contrast at cell edges.  Edges were then 
segmented by thresholding on negative values of this image.  Small features in this edge-detected 
image were then removed using morphological erosion, and cell boundaries were filled to give rise 
to solid segmentable objects.  Segmented objects were then enriched for cell-like objects based 
using selection on size, and eccentricity and integrated mCherry fluorescence intensity.  These cell 
segmentations were then used to calculate integrated GFP fluorescence intensity, using corrected 
GFP fluorescence images generated in Step (I).   We note that cells touching each other were 
sometimes segmented as a single object; these cells were re-segmented during manual cell tracking 
in step (V).  Segmented cells were either then tracked (Steps III-VI) or subject to a cytometric 
analysis of the entire imaged cell population.  For the latter, live-cells were first identified by gating 
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on mCherry versus object area axis, and then plotted as two-dimensional histograms of PU.1-GFP 
levels against time (Fig. 1E, 3B).     
 
(III) Automated cell tracking.  As a first pass, single-cell traces were inferred automatically from 
segmented cells using a least-squares optimization approach to minimize dissimilarity between cell 
pairs in adjacent images (38). Least-squares optimization was performed using the Munkres 
assignment algorithm to match nearby cells in adjacent fluorescence frames with each other.  In 
implementing this algorithm, we also took into account similarities in cell area, and also in mCherry 
and GFP fluorescence intensities.  The objective function E to be minimized is: 
 E = ??wij 
where the matrix element:  
 wij  =   [(xi – xj)2 + (yi – yj)2]0.5/Cdist  +  |Ai – Aj|/(Aj Carea) + |Gi – Gj|/(Gj CGFP) + |Ri – Rj|/(Rj CmCherry). 
and the summation is over all terms in the matrix.  Here matrix elements i and j give the indices of 
segmented cell objects for two successive mCherry fluorescence frames.  The first term on the right 
hand side corresponds to the Euclidean distance between the two objects i and j; the second, third 
and fourth terms correspond to the fold change in cell area, GFP integrated fluorescence intensity, 
and mCherry integrated fluorescence intensity.  The weighting values C give the cutoff values for 
these different parameters.  If any of these terms exceed unity, the matrix element is set to infinity, 
forbidding an assignment between these two objects.  This assignment algorithm was run for all 
pairs of successive mCherry fluorescence frames in timelapse image sequence to generate 
contiguous cell tracks.  Cell objects that were not matched to other cells in a successive frame were 
carried over to be re-matched to the next frame, and this carry-over continued until the either the 
cell was matched, or if a maximum number of carry-overs was reached.   
 
(IV) Manual refinement of cell tracking.  Cell tracks generated using automated tracking (Step III) were 
then subject to manual refinement to correct assignment errors and omissions, label cell division 
events and death events and split touching cells.  Individual cells were followed manually until they 
divided, died, exited from the field of view, or crossed paths with a nearby cell in a way that 
precluded unambiguous cell assignment between two successive frames.  Cell death events were 
characterized by an abrupt loss in mCherry fluorescence, increase in cell granularity as observed in 
brightfield images, and cessation of cell movement for moving cells.   To expedite manual 
segmentation and tracking, we developed a graphical user interface in MATLAB that allows the user 
to rapidly scroll through a timelapse movie, view multi-channel images with segmentation overlays, 
edit cell segmentations or assignments, and label cell division events (Fig. S7C).   
 
(V) Analysis of manually-refined cell tracks.  Manually-refined cell tracks were then used to generate 
individual cell lineage traces using a recursive graph-traversal algorithm.  These cell lineages were 
then used for calculation of cell cycle lengths and promoter activities in different cell populations 
(Fig. 1F-H, 3C-D, S7E).  For this analysis, single-cells were counted to fall within the defined 
population gates (Fig. 1D) only if more than 50% of the data points fell within the gate boundaries.  
Ancestors of macrophages (Mac early, Fig. 1H) were defined as cells with descendants that fell 
within the macrophage population gate, but were themselves outside the gate boundaries.  For 
promoter activity calculations, time traces of PU.1-GFP levels for single cells over their entire 
observed lifetimes were fit to straight lines (Fig. S7E), and slopes of the linear fits, which give the 
rate of PU.1-GFP accumulation over time, were used as estimates of PU.1 promoter activity.  For the 
mean cell cycle length for cells in a population, we used as an estimator the total number of 
observed frames for all cells in a given population divided by the total number of observed cell 
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division events in the population (Fig. 1H, 3D; see Fig. S18 for a graphical illustration).  This estimator 
is not biased by the rapid and entry and exit of cells out of the imaging field of view (without 
observed cell division), and also to take into account cells with long cell cycles that were not 
observed to divide.  To generate 95% confidence intervals for this mean cell cycle length estimate 
(Fig. 1H, 3D), a bootstrap method was used, where cells in a given population were randomly 
sampled with replacement to generate cell populations for calculating the distribution of mean cell 
cycle lengths. 
  All code is available from H.Y.K. (kueh@caltech.edu) upon request. 
Measurement of PU.1 protein stability 
For measurements of PU.1 protein stability (Fig. S6), macrophages derived from cultured FLPs were 
treated with 0.7 ?g/mL cycloheximide (Sigma) for different periods of time (0-9 hours), then stained for 
PU.1 protein using the procedure described below.  We note that higher concentrations of 
cycloheximide induced significant cell death within the observation time window, precluding 
measurement of PU.1 protein levels.  
Immunofluorescence staining of PU.1 protein 
For PU.1 immunofluorescence staining (Fig. S3, S6, S10), cells were fixed and permeabilized using the BD 
Cytofix/Cytoperm kit (BD BioSciences, San Jose, CA) and stained overnight in 5 ?g/mL antibody at 4oC.  
PU.1 levels were then measured using flow cytometry, or by fluorescence microscopy.  For cells 
analyzed using fluorescence microscopy, cell nuclei were identified by co-staining with Vybrant DyeCycle 
Violet (Invitrogen) and used for segmentation in acquired images.   
Gene expression analysis using quantitative RT-PCR 
Total RNA was extracted from EV or PU.1-transduced cells using the RNeasy RNA isolation kit (Qiagen) 
and reverse transcribed into cDNA (SuperScript RT III, Invitrogen).  cDNA from different samples were 
then mixed with the appropriate gene-specific primers (Table S4) and a quantitative PCR master mix 
reagent (SYBR GreenER, Invitrogen), and run on a real-time PCR machine (7900HT, Applied BioSystems).  
Reactions were run in triplicate, and relative expression levels were calculated based on median 
expression values of two biological replicates, using ?-actin as a normalization control.  Primers for a 
number of genes were designed with the aid of an online tool (39).   
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Mathematical Appendix
Here, we analyze a stochastic single-cell model of a positive feedback loop between PU.1 and
the cell cycle, as experimentally observed. We show that this circuit architecture can by itself
maintain two stable steady-states: a slow-dividing diﬀerentiated state with high levels of PU.1, and
a fast-dividing progenitor state with lower levels of PU.1, in agreement with the observed PU.1
and cell cycle regulation in developing macrophages. We next compare the performance of this
cell-cycle coupled feedback loop to that of a simple transcriptional positive feedback loop using
the framework of mathematically-controlled comparisons, as developed by Savageau [45]. In this
methodology, models representing alternate circuit architectures are constrained to be as similar
as possible (see below), and are evaluated using deﬁned performance objectives. We show that,
for the parameters examined, cell-cycle coupled feedback enables cells to persist in a slow-dividing
state for longer periods of time when gene expression is noisy. Finally, we consider a hybrid circuit
containing both transcriptional and cell-cycle coupled feedback loops, and show that it can generate
three stable steady-states that recapitulate PU.1 levels and cell cycle lengths for the observed pro-B,
progenitor and macrophage populations respectively.
1. Model of a cell-cycle coupled feedback loop
In this model of positive feedback between PU.1 and the cell cycle, transcription and translation,
together with mRNA and protein degradation, are described by ﬁrst-order chemical reactions1(Fig.
S15A, left):
reaction rate
m → m+ 1 αmV (t) (1)
m → m− 1 δmm (2)
p → p+ 1 αpm (3)
p → p− 1 δpp. (4)
1Here, transcription, translation, as well as mRNA and protein degradation are approximated using simple ﬁrst-
order chemical kinetics; while the detailed kinetics of these processes are more complex in cells, our subsequent
analysis, together with existing theory [46] will show that our conclusions hold independent of the exact kinetic form
of these processes.
1
Here m and p denote PU.1 mRNA and protein copy numbers, and V (t) is the nuclear volume,
given by:
V (t) = V0 if t < τ1 (5)
= V0[1 + (t− τ1)/τ2] if τ1 < t < τ1 + τ2 (6)
Here τ1 is the duration of the G1 phase of the cell cycle, and τ2 is the combined duration of the S,
G2 and M phase. The beginning of the cell cycle is taken to be t = 0. Here, nuclear volume remains
constant at V0 during G1 and increases linearly to twice its initial volume during the combined
S-G2-M phase (Fig. S15A, center). Note here that mRNA transcription scales with nuclear volume
to account for the increase in DNA copy number during DNA synthesis. To model the inhibition
of cell cycle progression by PU.1, we assume that PU.1 arrests cells at a G1 transition checkpoint
above a threshold concentration, such that:
τ1 = min
[
T, τmax1
]
, where (7)
T = {t | (p(t)/V < πc) ∧ (t > τmin1 )}
Here τmin1 represents the time it takes for cells to reach the G1 transition checkpoint; release from
this checkpoint either occurs immediately after PU.1 protein concentration falls below the critical
value πc (representing the minimum of the set of times T ), or when a maximal time τ
max
1 is reached,
whereby the G1 checkpoint is released by a PU.1-independent mechanism (Fig. S15A, right). In
this model, cells progress immediately to S phase, and the combined time of the S-G2-M phase τ2 is
taken to be constant. Finally, the cell divides at time (τ1 + τ2), whereby PU.1 mRNA and protein
are randomly partitioned between the two daughter cells following a binomial distribution. The
reactions described here were simulated using the Gillespie algorithm [44], where cell cycle events
(G1 checkpoint release and cell division) were executed concurrently with the stochastic simulations
of mRNA and protein level changes. In these simulations, we chose kinetic parameters relevant to
a mammalian cell context (Table S5).
From stochastic simulations, we found that this cell-cycle coupled positive feedback loop can
generate two states that can persist over many cell cycles, a slow-dividing state with high PU.1
protein levels, and a fast-dividing state with low PU.1 protein levels (Fig. 4A). The system could
switch spontaneously from a slow-dividing high PU.1 state to a fast-dividing low PU.1 state due
to stochastic ﬂuctuations in mRNA and protein levels (Fig. S15B), though, under the parameter
2
conditions examined, these switching events were rather infrequent (Fig. S15B, ∼1200 hours).
These results indicate that a cell-cycle coupled feedback loop can by itself generate two stable
states with diﬀerent regulatory factor levels.
2. Iterative map analysis of the cell-cycle coupled feedback loop
How does a cell-cycle coupled feedback loop generate two stable-states, and how do these steady-
states depend on parameter values? To answer this question, we develop an analytical framework
for examining steady-state stability using iterative maps. First, deﬁne pn to be the level of PU.1
protein at the beginning of the nth cell cycle. To gain analytical insight, we treat the problem
deterministically, assuming that there exists a function that maps the level of PU.1 protein at the
beginning of the (n+ 1)th cell cycle to that at the beginning of the nth cell cycle, as follows:
pn+1 = f(pn) (8)
To further simplify the problem, we take the limit where the protein is completely stable, such that
it accumulates at a constant rate r over time2. These assumptions approximate our experimental
measurements showing that PU.1 has a half-life of ∼ 70 hours (Fig. S6). In this limit, the iterative
function in (8) is given by:
f(pn) =
rtpro + pn
2
if pn < pcrit
=
rtmac + pn
2
if pn > pcrit. (9)
Here, tpro and tmac(> tpro) give the cell cycle lengths for progenitor and diﬀerentiated states, and
pcrit is a critical level of pn above which the system switches to a slow-dividing state. In this
simple model, pcrit but will be slightly lower than pc = πcV , the threshold PU.1 level required
for maintaining G1 checkpoint arrest (Eq. 7), as PU.1 protein levels will accumulate during G1;
moreover, in this discrete model, we do not explicitly account for the diﬀerent phases of the cell
cycle but instead absorb their eﬀective contributions into the reduced set of parameters described
above.
2To calculate this iterative function for the general case where protein degradation is signiﬁcant and synthesis
rates are not necessarily constant, we can integrate the rate equations for gene expression over the length of a cell
cycle using pn as the initial protein level.
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By plotting Eq. 9 against a straight line with slope unity, we can generate cobweb plots that
demonstrate the existence of two stable steady-states, one with low PU.1 levels, and another with
high PU.1 levels (Fig. S16). To solve for the steady-state of the system, we solve for p∞ = f(p∞).
Two solutions are possible:
plow = rtpro and phigh = rtmac. (10)
From visualization of the phase plot in Fig. S16, the following parameter conditions for bistability
emerge:
rtpro < pcrit < rtmac. (11)
This states that the critical level of PU.1 protein required at the beginning of the cell-cycle for
cell-cycle lengthening pcrit needs to fall between the projected low and high values for steady-state
PU.1 levels. If pcrit does not fall within these bounds, then the iterative function (Eq. 9) will
intersect with the straight line of slope unity only once, giving rise to one stable steady-state.
3. Mathematically-controlled comparison of a cell-cycle coupled feedback with an
alternate circuit architecture
What are possible selective advantages to utilizing cell-cycle coupled feedback loop involving PU.1
to maintain a slow-dividing diﬀerentiated state? Potential insights into this question can be gained
by using the technique of mathematically controlled comparisons [45] to compare the cell-cycle
coupled feedback loop to alternative circuit architectures that can also generate bistability and
maintain a slow-dividing diﬀerentiated cell state. In this method, models from alternative designs
are constrained to be as similar as possible, and then evaluated according to deﬁned performance
criteria. This method allows for fair comparisons of alternate circuit designs and is thus likened to
a well-controlled competition experiment [45].
Here, we use mathematically-controlled comparison to compare the cell-cycle coupled feedback
loop described above to a hypothetical transcriptional positive feeedback circuit where PU.1 ac-
tivates its own transcription. In this model, PU.1 also inhibits the G1 to S transition above a
threshold level, causing cell-cycle arrest in diﬀerentiated cells, but is instead maintained at two dif-
ferent steady-state levels through the transcriptional auto-regulatory loop (Fig. S17A, right). We
chose this circuit architecture for this comparison as it represents a minimal pure transcriptional
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feedback that supports a slow-dividing diﬀerentiated state; our results here do not rule out the
existence of other circuit transcriptional feedback architectures that may match or out-perform the
cell-cycle coupled feedback loop according to the deﬁned performance objectives.
Transcriptional feedback model
The equations describing the transcriptional feedback loop are the same to that for the cell-cycle
coupled feedback loop (Eq. 1-7), except that we modify the mRNA synthesis rate to incorporate
positive feedback, as follows:
reaction rate
m → m+ 1 α(1)m V if p/V ≤ πt
α(2)m V if p/V > πt (12)
where α
(1)
m < α
(2)
m . Here we have modeled the dependence of PU.1 transcription rate on nuclear PU.1
concentration by a step function, assuming a highly-cooperative response of the PU.1 promoter to
levels of PU.1. It is also possible to model positive transcriptional feedback using other transfer
functions, and our subsequent study of the hybrid feedback loop will utilize a Hill function to model
positive feedback (see below); however, we have chosen here a step-function for transcriptional
activation, as it provides a direct comparison with the threshold for PU.1-mediated cell-cycle arrest,
which also implies a step-like change in control of cell division rate. Our subsequent analysis of this
system will show that our main conclusions do not depend on the exact functional form of positive
feedback.
An important diﬀerence between the cell-cycle coupled feedback and transcriptional feedback
models lies in the magnitude of rate of protein degradation, given by δp in the models. For the
cell-cycle coupled feedback loop, the PU.1 protein degradation rate must be small compared to the
rate of progenitor cell division:
δp < (τ
min
1 + τ2)
−1 (13)
Because PU.1 protein is stable, it can accumulate as a result of cell-cycle lengthening, thus allowing
the cell-cycle coupled positive feedback loop to be closed (Fig. S17A, left). In contrast, for the
transcriptional positive feedback loop, the PU.1 protein degradation rate must be set to be larger
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than the progenitor cell division rate:
δp > (τ
min
1 + τ2)
−1 (14)
The faster degradation rate prevents PU.1 protein from accumulating as a result of cell-cycle length-
ening, and render’s PU.1’s eﬀective degradation independent of the cell cycle length. This ensures
that, for the purposes of this comparison, positive feedback occurs exclusively through transcrip-
tional PU.1 auto-regulation and not through cell-cycle mediated PU.1 accumulation. As we will
see, this diﬀerence in protein stabilities between these two models will provide the key diﬀerence
in the performances of the two models. It is possible to envision models where PU.1 protein is
stable, and thus both transcriptional and cell-cycle coupled feedback models are operational at the
same time; the functional properties of such hybrid feedback models will be interesting to study,
and we analyze one instance of such a hybrid feedback model in the context of PU.1 regulation in
pro-B cells, progenitors and macrophages (see below, and Fig. 4B-C). However, in order to clearly
characterize the diﬀerences in the functional properties between the two circuit architectures, we
perform this comparison using a regime of this extended model where only the transcriptional
feedback loop is active.
Constraints on the two models
To enable a mathematically-controlled comparison of the cell-cycle coupled feedback loop with the
transcriptional feedback loop, it is necessary to constrain the parameter values of these two models
such that they are as similar as possible. As a starting point for this comparison, we adopted
the parameters we used for the cell-cycle coupled feedback loop simulations (Fig. S15), and chose
parameters of the transcriptional feedback model such that the following constraints were met:
1. Both models generate a slow-dividing high-PU.1 state, and a fast-dividing low-PU.1 state.
2. The average steady-state PU.1 protein levels in the high-PU.1 and low-PU.1 states are the
same for both models.
3. The cell cycle lengths in the high-PU.1 and low PU.1 states are the same for both models.
4. Both models have the same mRNA transcription and degradation rates in the high-PU.1
state. This ensures that both models have similar mRNA ﬂuctuations in the slow-dividing
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high PU.1 state3.
5. Both models have the same critical PU.1 concentration for G1/S arrest (πc); furthermore,
the critical PU.1 concentration for transcriptional activation in the transcriptional feedback
model (πt, Eq. 12) is also set to the same value. This choice of PU.1 threshold levels equalizes
the extent of the basins of attraction for both models.
After implementation of these constraints for the transcriptional feedback loop model, there remains
one free variable, as translation rate αp and protein degradation rate δp can still vary but are
constrained to have the same ratio C. Here, we will perform the comparison using one ﬁxed value
of (αp, δp), where δp is much larger than the cell division rate for the transcriptional feedback loop,
as discussed above. For a more exhaustive comparison, one can simulate the model for diﬀerent
parameter values satisfying the relation αp/δp = C within the bounds speciﬁed by Eq. 14; however,
our subsequent analysis will show that this is not necessary, as the main results of this model do
not depend on the exact values chosen for these parameters.
Performance objectives
In choosing an performance criterion with which to compare these two systems, we surmised that
maintaining a stable slow-dividing diﬀerentiated state amid noisy gene expression may be an impor-
tant functional objective of the system, as failure to do so can result in a diﬀerentiation arrest and
leukemic transformation [16-19]. Therefore, we used as a performance criterion the average time
of spontaneous switching from the slow-cycling high-PU.1 (diﬀerentiated) state to the fast-cycling
low-PU.1 (progenitor) state.
Results and analysis
Here, we simulated both feedback loop models using parameters ﬁxed by the constraints described
above (see Table S5). We started these simulations at t = 0 in the slow-dividing high-PU.1 state,
3By model construction, the transcriptional feedback model will also have lower mRNA transcription rates in the
low-PU.1 state, in contrast to the cell-cycle coupled feedback model, where mRNA transcription rates are constant.
This may aﬀect the stability of the low-PU.1 (B-cell potentiating) state, although that is not investigated here in
detail; instead, to investigate the basis for macrophage developmental stability, we examine only the switch from
the high PU.1 state to the low PU.1 state, which is not aﬀected by PU.1 mRNA levels in the low PU.1 state.
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and then measured the time it took for the system to spontaneously switch to the fast-dividing
low-PU.1 state. These simulations showed that the transcriptional feedback loop can also generate
a slow-dividing PU.1-high state and a fast-dividing PU.1-low state (Fig. S17B). Cell-cycle lengths,
PU.1 protein levels, as well as PU.1 mRNA levels in the PU.1-high state were very similar to those
obtained for the cell-cycle coupled feedback loop (Fig. S17B, left versus right). However, we found
that the slow-dividing state generated by transcriptional feedback switched spontaneously to a fast-
dividing progenitor state more rapidly (Fig. S17B, right), indicating that this slow-dividing state
is less stable than the one maintained by cell-cycle coupled feedback. To further test this idea, we
repeated these simulations one hundred times for each model, and used this data to calculate the
percentage of cells persisting in the high-PU.1 slow-dividing state as a function of time (Fig. S17C).
For the cell-cycle coupled feedback model, we found that most cells (> 90%) maintained the slow-
dividing high-PU.1 state for over 200 hours, or 4 macrophage cell cycles (Fig. S17C, solid lines); in
contrast, for the transcriptional feedback model, almost all cells (> 90%) had already switched to
the fast-dividing low-PU.1 state within 200 hours (Fig. S17C, dotted lines). This result indicates
that the slow-dividing high-PU.1 state maintained by the cell-cycle coupled feedback loop persists
over considerably longer periods of time compared to the corresponding state for the transcriptional
positive feedback loop, under the constrained parameter conditions of these simulations.
The cause of these diﬀerences in steady-state stability between the two models can be seen
from an examination of the PU.1 mRNA and protein time traces for the two models (Fig. S17B).
For both feedback models, mRNA levels ﬂuctuated rapidly due to stochastic mRNA synthesis and
degradation, and the magnitude of these ﬂuctuations were similar (Fig. S17B, top); however, PU.1
protein level ﬂuctuations were considerably faster and larger in amplitude for the transcriptional
feedback loop compared to the cell-cycle coupled feedback loop (Fig. S17B, middle). These larger
and more frequent ﬂuctuations in PU.1 protein levels for the transcriptional positive feedback loop
increases the rate at which PU.1 levels spontaneously fall below the critical threshold for mediating
cell-cycle arrest (Fig. S17B, dotted line). In contrast, PU.1 protein levels accumulated more
steadily for the cell-cycle coupled feedback loop, despite the ﬂuctuations in mRNA levels.
Insights into the generality of the diﬀerences in steady-state stability between these two models
can be obtained by examining analytical expressions for the expected magnitude and frequency of
protein ﬂuctuations for the stochastic gene expression model utilized here (Eq. 1-4). From previous
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work [46], we know that the relative magnitude of protein level ﬂuctuations is given by:
σ2p
〈p〉2 =
1
〈p〉 +
1
〈m〉 ·
δp
δp + δm
(15)
where the average mRNA and protein levels at steady-state are:
〈m〉 = αm
δm
(16)
and
〈p〉 = αpαm
δmδp
(17)
respectively4. In our comparison, both models are constrained to have the same average protein
levels 〈p〉, mRNA levels 〈m〉, as well as mRNA degradation rate δm. However, the protein degrada-
tion rate δp diﬀers signiﬁcantly for the two models; the protein degradation rate for the cell-cycle
coupled feedback loop is much lower than that for the transcriptional positive feedback loop model
(0.02 hr−1 versus 0.3 hr−1), and is also considerably lower than the mRNA degradation rate (δm
= 0.3 hr−1). This lower protein degradation rate – a consequence of the long PU.1 protein half-
life in the cell-cycle coupled feedback model – allows the system to time-average ﬂuctuations in
mRNA levels, thus reducing the contribution of mRNA ﬂuctuations to the variability in protein
levels (i.e. the second term on the right hand side of Eq. 15). From other work [46], we know that
this time-averaging behavior of stable protein is a general property of a gene-expression system
and is independent of the detailed kinetics of individual steps; hence, we expect our ﬁndings to
also generalize to more models that consider in more intricate detail the processes of transcrip-
tion, translation, and mRNA/protein degradation. Such time-averaging to maintain steady-state
stability may be especially important for mammalian systems, where mRNA copy numbers are
2-4 orders of magnitude lower than protein copy numbers [24], such that the transcriptional noise
term in Eq. 15 dominates. We note that, in this transcriptional-noise dominated regime, changes
in average protein levels due to translational rate changes would be expected to have little eﬀect
on the relative magnitude of protein ﬂuctuations; consistent with this assertion, simulations done
with a tenfold reduction in both protein copy numbers (by translation rate reduction) and feedback
activation thresholds gave rise to the same conclusions (data not shown).
4For simplicity, we have dropped the cell volume term in Eq.1, which is taken to be of order unity; this omission
is not expected to aﬀect our conclusions here.
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To obtain the timescales of protein ﬂutuations in the system, we can analyze a deterministic
equivalent of this gene expression model, given by:
d
dt
⎛
⎝m− 〈m〉
p− 〈p〉
⎞
⎠ =
⎛
⎝−δm 0
αp −δp
⎞
⎠
⎛
⎝m− 〈m〉
p− 〈p〉
⎞
⎠ (18)
From a solution of this linear system, we can show that the two characteristic timescales for protein
levels are given by:
T1 = 1/δm (19)
T2 = 1/δp. (20)
As a result of the slower protein degradation rate δp, the cell-cycle coupled feedback loop has a
considerably longer protein relaxation timescale T2( T1) compared to the transcriptional positive
feedback loop, where mRNA and protein degradation rates are similar (T2 ∼ T1). Consequently,
protein levels will ﬂuctuate about the average steady-state PU.1 value on a slower timescale. Taking
these analytical results together with numerical simulations performed above, we conclude that the
cell-cycle coupled feedback loop exhibits smaller and slower protein ﬂuctuations than the transcrip-
tional positive feedback loop, and consequently shows a signiﬁcantly reduced rate of spontaneous
switching between diﬀerent steady states. This result suggests that the cell-cycle coupled feedback
architecture more eﬀectively maintains a stable growth-arrested state amid noisy gene expression,
and could provide advantages compared to the transcriptional auto-regulatory circuit in systems
when such stability is important.
4. Analysis of a hybrid feedback loop that generates three stable steady-states
We next consider a hybrid feedback model where PU.1 positively regulates itself, both through
cell-cycle lenghtening, and also by transcriptional activation. We will show that this hybrid
transcriptional/cell-cycle feedback architecture can give rise to three stable steady states corre-
sponding to the pro-B, progenitor and macrophage populations respectively.
As with the transcriptional feedback loop analyzed above, the equations describing the hybrid
feedback loop are the same as that for the cell-cycle coupled feedback loop (Eqs. 1-7), except with
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the following modiﬁcation of the mRNA synthesis rate:
reaction rate (21)
m → m+ 1
[
α(1)m + (α
(2)
m − α(1)m ) ·
(p/V )N
(p/V )N + πNt
]
V (22)
Here mRNA production rate increases from a basal rate α
(1)
m to a maximal rate α
(2)
m with Hill
coeﬃcient N and a half-maximal activation PU.1 concentration of πt. In choosing parameters for
simulations, we utilized the same cell cycle parameters (τmax1 , τ
min
1 , V0, πc, τ2), the same mRNA
degradation rate (δm), as well as the same protein production and degradation rates (αp, δp)
as those for the cell-cycle coupled feedback loop (see Table S5). We set the maximal mRNA
production rate (α
(2)
m ) to be the same as the constant mRNA production rate for the cell-cycle
coupled feedback model (αm). Furthermore, we assume the critical PU.1 concentration for half-
maximal transcription activation πt is considerably lower than that for PU.1-mediated G1 arrest
πc. This assumption is supported by our experimental ﬁndings that increasing PU.1 levels by
retroviral transduction does not further activate endogneous PU.1 transcription (Fig. 3), whereas
reducing PU.1 activity by dominant negative PU.1-ets does decrease PU.1-GFP expression (Fig.
S12). Moreover, the existence of this transcriptional feedback loop is generally supported by other
studies showing a role for positive feedback in the control of PU.1 transcription during lymphoid
and myeloid development [7, 10-14].
In simulations with the parameters described above (see also Table S5), we found that this
hybrid feedback loop can generate three stable states with PU.1 levels and cell cycle lengths that
loosely correspond to those found in pro-B cells, progenitors and macrophages respectively (Fig.
4B). When started with diﬀerent initial levels of PU.1 protein, the system can evolve into three
distinct steady-states: 1) A fast-dividing state with low levels of PU.1 (Fig. 4B, red); 2) A fast-
dividing state with intermediate levels of PU.1 (Fig. 4B, gray); 3) A slow-dividing state with high
levels of PU.1 (Fig. 4B, blue). These cell division rates and PU.1 levels respectively correspond to
those observed for the pro-B, progenitor and macrophage populations. Therefore, we propose that
this hybrid feedback model may provide a basis for analyzing PU.1 regulation during the B-cell
and macrophage fate determination.
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5. Phase plane analysis of the diﬀerent feedback architectures
To further understand how multiple stable states emerge from the cell-cycle coupled feedback
loop and the hybrid feedback loop simulated above, we consider an alternate model description of
these two feedback architectures, where stochastic eﬀects are neglected and cell division rates are
approximated by a continuous function. While this approach introduces further simpliﬁcations to
the single-cell models above, it will allow us to use phase diagrams to visualize individual steady-
states, providing insight into parameter requirements for multi-stability.
Based on the equations for the cell-cycle coupled feedback model (Eqs. 1-7) and the hybrid
feedback model (Eq. 21), we formulate a simpliﬁed model where we use a single ordinary diﬀerential
equation to describe the time evolution of PU.1 protein:
dp
dt
= A(p)− [C(p) +D]p (23)
where p is the level of PU.1, A is the rate of protein synthesis, C is the rate of cell division, and D
is the rate of protein degradation. The synthesis rate is either constant for the cell-cycle coupled
feedback model:
A(p) = A0 (24)
or
A(p) = Amin + (Amax − Amin) · p
M
KMp + p
M
(25)
for the hybrid feedback model. Here Amin and Amax are the basal and maximal rates of PU.1 syn-
thesis, and Kp is the critical PU.1 level required for half-maximal activation of PU.1 transcription.
For the both models, the rate of cell division is given by:
C(p) = Cmin + (Cmax − Cmin) · K
N
c
KNc + p
N
(26)
where Cmax and Cmin are the maximal and minimal rates of cell division respectively. The cell
division rate decreases when PU.1 levels increase, from an initial rate Cmax in progenitors to a
reduced rate Cmin in diﬀerentiated cells. KC gives the PU.1 level at which this decrease in cell
division rate is half-maximal, and N gives the eﬀective Hill coeﬃcient for this decrease. Note
that N need not be the same as M , the Hill coeﬃcient for PU.1 transcriptional activation, as it
will depend not only on PU.1/DNA interactions but also on the biochemistry of the PU.1 target
proteins responsible for mediating G1 checkpoint arrest. In stochastic simulations, we eﬀectively
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consider the limit where N → ∞, where PU.1 inhibits the G1 to S transition only above a certain
threshold. Using these equations, we generated phase diagrams by plotting PU.1 synthesis and
degradation rates against PU.1 levels, choosing parameters that loosely correspond to those used
in single-cell simulations (Fig. 4C, see Table S6 for parameters). System steady-states are then
given by intersections between these synthesis and degradation curves, and their stabilities can be
determined by the relative heights of these two curves to the left or right of the intersection.
This analysis gives insights into how the cell-cycle coupled feedback loop and the hybrid feedback
loop can generate two or three stable steady-states respectively. Due to a sharp decrease in the cell
division rate (Fig. 4C, top), the PU.1 dilution rate becomes non-monotonic, bending back on itself
to intersect the PU.1 synthesis curve three times (Fig. 4C, bottom). The outer two interections
then correspond to the two stable steady-states (Fig. 4C, blue and gray circles), while the middle
intersection represents an unstable steady-state that separates the basins of attraction for the two
stable steady-states. This phase space structure can emerge in the cell-cycle coupled feedback
loop, where synthesis rate is constant (Fig. 4C, gray), and also in the hybrid feedback loop, where
synthesis rate increases with PU.1 levels (Fig. 4C, black).
When the rate of PU.1 synthesis increases cooperatively with PU.1 levels, as is the case for the
hybrid feedback loop, the PU.1 synthesis curve can bend back to intersect the PU.1 dilution curve
two more times. The lower intersection corresponds to an additional stable steady-state (Fig. 4C,
red circle), and the higher intersection separates the basins of attraction for the two steady-states
with low and intermediate PU.1 levels. This analysis shows that the hybrid feedback loop can
generate three stable states with diﬀerent PU.1 levels and cell division rates, as also shown with
stochastic simulations (Fig. 4B). This analysis also reveals a model assumption that is critical for
the generation of three stable states, namely that the critical PU.1 protein level for half-maximal
activation of PU.1 transcription must be lower than that for half-maximal cell-cycle lengthening.
In an alternative regime where the PU.1 thresholds for cell-cycle lengthening and transcriptional
activation are similar, synthesis and degradation curves can only intersect with each other three
times, giving rise to a maximum of two stable steady-states.
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Supplementary Figure Legends 
Fig. S1:  Isolation of fetal liver progenitors (FLPs) from PU.1-GFP mice.  Flow cytometry plots showing 
FLP sort gates (P0 – P4; Lin-7AAD-cKit+CD27+).  Percentages give fraction of cells in the specified gate 
relative to that in parent gate.  Histogram shows distributions of PU.1-GFP levels for the FLP population 
(P4) and in the parent population (P3).  FLPs show a uniform level of PU.1-GFP. 
Fig. S2: Fetal liver progenitors (Lin-cKit+CD27+) have B-cell and myeloid lineage potential.  FLPs were 
sorted into individual wells, cultured for 7 days (5 ng/mL SCF, IL-7 and Flt3L +/- 0.5 ng/mL IL-3) and 
analyzed using flow cytometry.  A)  Flow cytometry plots showing surface CD19 (top) or CD11b (bottom) 
staining against PU.1-GFP for a starting culture with 100 cells (left), or for representative cultures of 
single-cells showing differentiation into B- (center) or  myeloid (right) lineages.  Cells shown here were 
cultured without IL-3.   B)  Single-cell B- or myeloid cell cloning frequencies of FLPs in cultures with or 
without 0.5 ng/mL IL-3.  B-cells are defined as CD19+PU.1-GFPlow cells, whereas myeloid cells are defined 
as CD11b+PU.1-GFPhigh cells.  Concurrent differentiation into B- and myeloid lineages from a single-cell 
was not observed under these conditions.  The addition of 0.5 ng/mL IL-3 promoted myeloid 
development at the expense of B-cell development.  Note that lower concentrations of IL-3 (0.1 ng/mL) 
were used for the other experiments in the paper to allow concurrent observation of B- and myeloid 
development. 
Fig. S3:  Nuclear PU.1 protein levels vary linearly with PU.1-GFP levels.   FLPs were cultured for 7 days 
and sorted for B-cells (CD19+PU.1-GFP-low), progenitors (Gr1-PU.1-GFP intermediate) and macrophages 
(PU.1-GFP high).  Sorted cells were then stained for PU.1 protein using an A647-conjugated anti-PU.1 
antibody, and analyzed using fluorescence microscopy.  A)  Fluorescence images showing DNA and PU.1 
immunofluorescence staining for different sorted cell populations obtained after seven days in culture.  
Scale bar = 10 microns.  B)  Mean nuclear PU.1 levels plotted against mean PU.1-GFP levels for different 
sorted cell populations.  Nuclear PU.1 levels were obtained by quantification of fluorescence images in 
A), whereas mean PU.1-GFP levels were obtained using flow cytometry.  Data points give mean and 
S.E.M. for the different cell populations (B: N=235; Pro: N=72; Mac: N=108).   
Fig. S4:  Cultured FLPs develop into macrophages (CD11b+F4/80+Gr1-PU.1-GFPhigh), granulocytes 
(CD11b+Gr1+F4/80-PU.1-GFPint) and pro-B cells (CD19+PU.1-GFPlow) over time in a cytokine-dependent 
manner.  Sorted FLPs were cultured in SCF, IL-3, FLt3L, IL-7 and M-CSF (or with components removed as 
indicated), and analyzed by flow cytometry.   A)  Histogram of PU.1-GFP levels (top), or flow cytometry 
plots of CD19, CD11b, F4/80 or Gr1 against PU.1-GFP levels for cells cultured for the indicated number of 
days in either complete cytokine cocktail (columns 1-3), or with a reduced cytokine cocktail missing the 
indicated components (columns 4-5).  Bars define PU.1-GFPlow, PU.1-GFPint and PU.1-GFPhigh cell 
populations.  Dotted lines show PU.1-GFP levels in input cells.  B)  Multi-parameter surface marker 
analysis of cell populations with different PU.1-GFP levels, as defined in A).  Flow cytometry plots show 
CD19 versus CD11b levels (top), or F4/80 versus Gr1 levels for different CD19/CD11b sub-populations as 
defined by the indicated quadrants. 
Fig. S5:  Macrophage differentiation and PU.1-induced cell cycle lengthening occurs selectively in 
Fc?R2/3low FLPs, but not in Fc?R2/3+ FLPs.  A)  Flow cytometry plots showing sort gates for the Fc?R2/3+ 
and Fc?R2/3low FLPs (Lin-cKit+CD27+).  Note that that Fc?R2/3+ and Fc?R2/3low FLPs express PU.1-GFP at 
similar levels (right).  B)  Fc?R2/3low (left) and Fc?R2/3+ (right) FLPs were cultured for 7 days in 5 ng/mL 
SCF, IL-7, Flt3L and 0.1 ng/mL IL-3, and analyzed by flow cytometry.  Plots show CD11b against PU.1-GFP 
(top), and Gr1 against PU.1-GFP for the CD11b+ cells, gated as shown above.  Fc?R2/3low FLPs give rise to 
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B-cells (PU.1-GFP low), macrophages and granulocytes, whereas Fc?R2/3+ FLPs give rise to granulocytes 
but not macrophages and B-cells.  C)  EV or PU.1-transduced Fc?R2/3low or Fc?R2/3+ FLPs were sorted, 
stained for CellTrace Violet, and cultured for 3 days in 5 ng/mL SCF, IL-7, Flt3L and 0.1 ng/mL IL-3.  Flow 
cytometry plots show CD11b (top), Gr1 (middle) and CellTrace Violet (bottom) against PU.1-GFP levels 
for the different transduced cell populations.  Histograms (bottom) compare CellTrace Violet levels for 
EV versus PU.1-transduced cells for either Fc?R2/3low FLPs (left) or Fc?R2/3+ FLPs (right).  Unstained 
controls (gray shaded) and initial CellTrace Violet levels at Day 0 (black) are also shown.  Results indicate 
that retroviral of transduction of PU.1 induces cell-cycle lengthening in Fc?R2/3low FLPs but not in 
Fc?R2/3+ FLPs.  Data are representative of three independent experiments. 
Fig. S6:  PU.1 protein has a half-life that spans multiple progenitor cell cycle lengths.   Fc?R2/3low FLPs 
were sorted, cultured in 5 ng/mL SCF, IL-7, Flt3L, M-CSF and 0.1 ng/mL IL-3 for 7 days, and then treated 
with 0.7 ?M cycloheximide for the indicated amounts of time.  In separate experiments (data not 
shown), we found that macrophages in culture are highly-sensitive to cycloheximide; by performing a 
titration, we determined this concentration of cycloheximide to be the maximal possible level that does 
not induce significant cell death, which confounds measurements.  We note that this concentration of 
cycloheximide is still over a magnitude higher than its measured IC50 for inhibition of protein synthesis 
in cultured cells [~0.05 ?M, from (40)].  Cells were then stained and analyzed by flow cytometry.  A)  
Histograms show PU.1 protein levels in developing macrophages (CD11b+) before cycloheximide 
treatment (gray dotted), or after cycloheximide treatment for the indicated amounts of time (black).  
Background PU.1 staining levels in a pro-T cell line not expressing PU.1 (SCID.adh2C2) are shown in gray.  
B)  Plots show mean PU.1 levels against elapsed time after CHX treatment for two independent 
experiments (left, right).  Curves show best fit of the data to a single exponential of the form f(t) = exp(-
t/?).  Best-fit values for ? are shown.  These results show that PU.1 has a half-life that is significantly 
longer than that of the progenitor cell cycle length (~10 hours), and can thus accumulate as a result of 
cell cycle lengthening. 
Fig. S7:  Experimental system for measuring PU.1-GFP levels and PU.1 synthesis rates in single cells 
using timelapse fluorescence microscopy.  A)  Schematic showing experimental parameters used for 
live-cell timelapse imaging.  Timelapse intervals between successive images for the indicated channels 
are given by ?t; horizontal and vertical offsets for tiling image acquisition are given by ?x and ?y 
respectively.  B)  Surface plot showing the correction function for uneven GFP fluorescence illumination 
by the imaging setup.  X- and Y- axes are measured in pixels.  The correction function was measured 
experimentally by imaging uniformly-sized fluorescent microspheres separately for each wavelength 
(see Supplementary Methods).  C)  DIC (top), mCherry (middle) and GFP (bottom) images showing the 
segmentation and tracking of cells between two successive timelapse images (left and right).  Yellow 
vertical and horizontal lines indicate the boundaries between adjacent tiled images along the x- and y- 
dimensions respectively.  Colored boundaries in the mCherry and GFP channels represents cell 
segmentation, with each distinct color representing a distinct cell track.  Numbers on the lower left give 
the elapsed time in hours; scale bar (lower right) represents 100 microns.  D)  Tree showing PU.1-GFP 
time traces for all cells tracked in a representative lineage.  Filled area above each horizontal line gives 
PU.1-GFP levels in single cells over time.  Branch points indicate cell division events, and termination of a 
cell trace reflects the exit of the cell from the imaging field of view.  Horizontal scale bar gives PU.1-GFP 
levels (104 arbitrary units), and vertical scale bar gives time (10 hours).  E)  Plot showing PU.1-GFP levels 
against time for cells in the example lineage in D).  Dots represent measured single-cell PU.1-GFP levels, 
and straight lines represent the best-fits by least-squares fitting.  Each distinct color represents a distinct 
cell in the lineage.   PU.1 promoter activity is given by the slope of the cells measured by least-squares 
fitting. 
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Fig. S8:  GFP is photo-stable under timelapse imaging conditions.  A T-cell lymphoma cell line 
(SCID.adh2C2) was infected with a GFP-expressing retrovirus (LZRS-GFP) and subject to timelapse 
imaging in the absence or presence of 10 ?g/mL cycloheximide (CHX), a protein synthesis inhibitor.  
Imaging exposure conditions were similar to those shown in Fig. S7 (GFP channel exposure time – 
800 ms, timelapse interval – 12 minutes, 60X 1.4 NA objective, ND2.0).  GFP levels were tracked over 
time in single cells before (left) and after (center, right) addition of CHX.  Time of CHX addition is given 
by vertical arrows (center, right).  Straight lines represent best least-squares fit to the function 
f(t) = A(1+kt); k represents the GFP accumulation rate (if positive) or the combined 
photobleaching/degradation rate (if negative).  Values of k for GFP levels after CHX addition are much 
smaller than the cell division rate (~10-1/hr), indicating that the half-life of fluorescing GFP greatly 
exceeds that of the cell cycle time under our imaging conditions. 
Fig. S9:  Representative lineage trees showing PU.1-GFP regulation in different cell populations.  Trees 
show PU.1-GFP levels over time in single cell lineages within the following populations:  Progenitors with 
high PU.1 promoter activity, Progenitors with low PU.1 promoter activity, Macrophages, and B-cells.  
Green shaded areas above branches represent single-cell PU.1-GFP levels, with vertical scale bar 
denoting 100,000 PU.1-GFP levels (arbitrary units).  Horizontal direction represents time, with horizontal 
scale bar representing 20 hours.  Asterisks indicate cell lineages in Fig. 1F.  Red crosses indicate cell 
death events as seen by imaging.  Cell death events were rare for the cells analyzed (4.0%, or 16 out of 
403 cells were observed to die). 
Fig. S10: Induced cell-cycle lengthening by CDK inhibitors p21 or p27 increases PU.1 protein levels.  A)-
B) Sorted FLPs were then cultured and concurrently transduced with empty vector, p21 or p27 retroviral 
constructs.  Transduced cells were then re-sorted after four days for cells with different levels of PU.1-
GFP, stained using an A647-conjugated ?PU.1 antibody, and re-analyzed using flow cytometry.  A) 
Histograms showing sort gates for transduced cell populations with low, intermediate and high PU.1-
GFP levels.  B) PU.1 protein (?PU.1-A647) against PU.1-GFP levels for EV (left), p21 (middle) and p27 
(right) transduced cell populations with different PU.1-GFP levels.  C) Median PU.1 protein levels against 
median PU.1-GFP levels obtained from flow cytometry plots in A).  Data represent mean and standard 
deviation of two experiments. 
Fig. S11: PU.1-ets blocks wildtype PU.1 function.  A)  Cartoon showing the domain organization of 
wildtype PU.1 and the PU.1-ets construct used in this study.  The N-terminal trans-activation (TA) 
domain of PU.1 is enriched for aspartic acid (D), glutamic acid (E) and glutamine (Q) residues.  B)  Cells 
from a T-cell lymphoma cell line (Adh-2C2) were infected with various constructs as indicated on the top 
of each panel.  After 48 hours, T-lineage cells were detected by CD25, and diversion to the myeloid 
lineage was determined by analyzing the surface up-regulation of the myeloid marker CD11b as 
described elsewhere (41).  The data in the FACs-plots is representative of 2 independent experiments 
and shows that PU.1-ets effectively blocks myeloid diversion (CD25 down-regulation and CD11b up-
regulation) by the wildtype PU.1 construct.  C)  PU.1-ets reduces the levels of known PU.1 positive target 
genes (42).   E14.5 Bcl2-transgenic FLPs were cultured on Op9-DL1 for four days, transduced with empty 
vector (EV) control or PU.1-ets carrying retroviruses and sorted as infected DN2 (cKit+, CD44+, CD25+) 
cells.  mRNA was enriched following total RNA extraction and used to build cDNA libraries which were 
sequenced using an Illumina HiSeq sequencer, essentially as described previously (43).  Sequence reads 
were mapped to the NCBI mouse genome build (mm9) using Bowtie (http://bowtie-
bio.sourceforge.net/index.shtml) and analyzed for differential expression using Cufflinks 2.0 
(http://cufflinks.cbcb.umd.edu/).  FPKM values for selected genes from 2 independent experiments 
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were normalized to their EV expression levels and the mean was plotted in the graph above.  Error bars 
show one standard deviation.  *indicates p < 0.05 using Student’s t-test.  The gene expression data 
shown in the bar chart is from another related study (Champhekar, A., Damle, S., Nutt, S.L., Carotta, S., 
Rothenberg, E.V., in preparation).  
Fig S12:  Inhibiting PU.1 activity using PU.1-ets promotes PU.1-GFP down-regulation, but does not 
accelerate pro-B cell formation.  Fc?R2/3low FLPs transduced with either empty vector (EV) or the PU.1 
Ets DNA binding domain (PU.1-ets) were sorted, cultured for 5 days in 5 ng/mL SCF, IL-7, Flt3L and 0.1 
ng/mL IL-3 and analyzed.  Flow cytometry plots (left) show CD19 (top) and CD11b (bottom) against PU.1-
GFP levels for different transduced populations.  Histograms (right) compare PU.1-GFP levels for EV 
versus PU.1-ets transduced cells.  Data are representative of results from three independent 
experiments.   
Fig. S13:   Exogenous PU.1 expression inhibits PU.1 down-regulation and CD19 up-regulation.   FLPs 
retrovirally transduced with either an empty vector (top) or PU.1 (bottom) were sorted, cultured for five 
days and analyzed using flow cytometry.  Histogram (left) shows PU.1-GFP levels  (left), and flow 
cytometry plots show CD11b against PU.1-GFP (center), or CD19 against PU.1-GFP (right).  These plots 
show that PU.1-transduced FLPs give rise to lower percentages of PU.1-GFP low cells (left), and CD19-
expressing cells (right).  The CD19 fluorescent-conjugated antibody used here (CD19-e450, eBio1D3) 
gave considerably weaker staining than the one used in Figs. 1 and S4 (CD19-PE, 6D5), or the one used in 
Fig. S12 (CD19-PE, eBio1D3).  
Fig. S14:  Representative lineage trees comparing PU.1-GFP regulation in FLPs transduced with empty 
vector or PU.1.  Trees show PU.1-GFP levels over time in single cell lineages for EV-transduced FLPs 
(top), and PU.1-transduced FLPs (bottom).  Green shaded areas above branches represent single-cell 
PU.1-GFP levels, with vertical scale bar denoting 100,000 PU.1-GFP levels (arbitrary units).  Horizontal 
direction represents time, with horizontal scale bar representing 40 hours.  Dashed lines connecting the 
ancestors of each lineage indicate offset of initial observation from t = 0 hours.  Asterisks indicate cell 
lineages in Fig. 3.  Red crosses indicate cell death events.  Cell death events were rare, and transduction 
with exogenous PU.1 did not increase the frequency of cell death for the cells analyzed (empty vector – 
7.9%, or 12 out of 152 cells died; PU.1 – 3%, or 4 out of 133 cells died). 
Fig. S15:  Stochastic single-cell model of a cell-cycle coupled positive feedback loop.  A)  Description of 
model, with biochemical reactions for gene expression (left), cell-cycle dependent nuclear volume 
changes (middle), and different mechanisms for triggering G1/S checkpoint release (right).  B)  Results of 
a representative stochastic simulation run, showing the time evolution of PU.1 mRNA levels (top), 
protein levels (middle) and nuclear volume (bottom), along with corresponding histograms of PU.1 
mRNA and protein copy numbers (left).  Simulations were performed using the Gillespie algorithm  (44).   
Here, the system was started at the slow-dividing high-PU.1 state to test whether this state could be 
maintained over many cell divisions.  Model parameters are given in Table S5.   Area shaded in yellow is 
magnified and shown as an inset on the right.  In this simulation run, the system maintains a slow-
dividing high PU.1 state for ?1200 hours, then switches spontaneously to the fast-dividing low PU.1 
state.  Threshold PU.1 level for cell-cycle arrest is indicated by the horizontal gray line (inset), whereas 
the time at which the G1/S transition is released during system switching is given by the vertical red line 
(inset).  The same simulation run is shown again in Fig. S17B (left) for comparative purposes. 
Fig. S16: Iterative map reveals bi-stability mediated by a cell-cycle coupled feedback loop.  Iterative 
function (thick line) relates the initial protein levels after the nth cell division to initial protein levels after 
4 
 
the (n+1)th cell division.  This function intersects twice with the straight line of slope unity (thin line), 
giving rise to two attractors (circles).  Cobweb plots (dotted lines) show two sample trajectories with 
different initial starting conditions falling into the two different steady states.  Arrows indicate direction 
of the system flows.  
Fig. S17: A cell cycle-coupled feedback loop more effectively stabilizes a slow-dividing differentiated 
state compared to a pure transcriptional feedback loop.  A) Model diagram for a cell-cycle coupled 
feedback loop (left), or a pure transcriptional feedback loop (right).  Positive feedback loops are 
highlighted in blue, and spiral denotes the cell cycle.  B) Time traces comparing the stability of a slow-
dividing differentiated state maintained by either cell-cycle coupled feedback (left) or transcriptional 
feedback (right).  Red line (right) indicates time of spontaneous reversion to a fast-dividing state for the 
transcriptional feedback loop model.  C)  Fraction of slow-dividing cells persisting as a function of 
elapsed time for either the cell-cycle coupled positive feedback model (solid line) or the transcriptional 
positive feedback model (dotted line).  Simulation parameters are chosen to enable a mathematically-
controlled comparison between the two models [(45), see Mathematical Appendix], and are given in 
Table S5.   
Fig. S18:  Method for unbiased estimation of cell cycle lengths in whole cell populations.  Lineage trees 
show lifetimes of individual cells for two fictitious populations, A and B.  Length along x axis is 
proportional to time.  Vertical gray bars indicate beginning and end of observation window.  Lines 
shaded with yellow indicate cells with completely-observed lifetimes (between two observed cell 
divisions).  Red cross indicates observed cell death event.  Estimator for mean cell cycle length of a cell 
population is given by the sum of observed lifetimes for all cells (with both complete and incomplete cell 
cycles), divided by the number of observed cells (i.e. NA = 15 for population A, NB = 11 for population B).  
In this example, accounting of only the cells with complete cell cycles (shaded yellow) will lead to a 
biased estimate of cell cycle length, as it will be influenced by differential kinetics of cell death and cell 
appearance/disappearance between the two populations, as well as truncated cell lifetimes due to finite 
window of observation.  We note that this estimator is equivalent to the maximum likelihood estimator 
for the mean transition time of a first-order process that occurs at a constant fixed rate.(46)
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Table S1:  List of antibodies 
Antibody Clone Supplier Experimental Usage 
 
Ter119 biotin TER-119 ebioscience Depletion of lineage positive cells from fetal 
liver  
F4/80 biotin BM8 eBioscience Depletion of lineage positive cells from fetal 
liver  
Gr-1 biotin RB6-8C5 eBioscience Depletion of lineage positive cells from fetal 
liver  
CD11c biotin N418 eBioscience Depletion of lineage positive cells from fetal 
liver  
NK1.1 biotin PK136 eBioscience Depletion of lineage positive cells from fetal 
liver  
CD19 biotin eBio1D3 eBioscience Depletion of lineage positive cells from fetal 
liver  
cKit-APC-eFluor780 2B8 eBioscience Sorting of fetal liver progenitors 
(Fig. 2, S2, S6, S5, S10, S12) 
cKit-PacBlue 2B8 BioLegend Sorting of fetal liver progenitors 
(Fig.  1, 3, S1, S3, S4, S10, S13, S14) 
CD27-APC PC61.5 eBioscience Sorting of fetal liver progenitors 
(all experiments) 
Fc?R2/3 (CD16/32)- e450  93 eBioscience Sorting of Fc?R2/3 +/low  fetal liver 
progenitors (Fig. 2C-D, 3E, S5, S6, S12) 
Streptavidin-eFluor450  eBioscience Sorting of fetal liver progenitors 
(Fig. S2) 
Streptavidin-Brilliant Violet 
570 
 Biolegend Sorting of Fc?R2/3 +/low  fetal liver 
progenitors (Fig. 2C-D, 3E, S5, S6, S12) 
Streptavidin-APC-eFluor780  eBioscience Sorting of fetal liver progenitors 
(Fig.  1, 3, S1, S3, S4, S9, S13, S14) 
Streptavidin-PerCP-Cy5.5  eBioscience Sorting of fetal liver progenitors 
(Fig. S1, S10) 
7-aminoactinmycin D  Invitrogen Sorting of fetal liver progenitors 
(Fig. S1, S10) 
CD19 PE 6D5 eBioscience Flow cytometry analysis of cultured 
progenitors (Fig. 1, S2, S4) 
Gr-1 APC RB6-8C5 eBioscience Flow cytometry analysis of cultured 
progenitors (Fig. 1, S4) 
CD11b-APC-eFluor780 M1/70 eBioscience Flow cytometry analysis of cultured 
progenitors (Fig. 1, 2, 3, S2, S4, S5, S12, S13) 
CD11b-eFluor450 M1/70 eBioscience Flow cytometry analysis of cultured 
progenitors (Fig. S6) 
F4/80-eFluor450 BM8 eBioscience Flow cytometry analysis of cultured 
progenitors (Fig. 1, S4) 
CD19-eFluor450 eBio1D3 eBioscience Flow cytometry analysis of cultured 
progenitors (Fig. S13) 
CD19-PE? eBio1D3 eBioscience Flow cytometry analysis of cultured 
progenitors (Fig. S12) 
?PU.1-AlexaFluor647 9G7 Cell signaling and 
technology 
Immunofluorescence staining of PU.1 
protein in single cells (Fig. S3, S6) 
  
1 
 
Table S2: DNA constructs 
Gene expressed Retroviral backbone Experimental Usage 
 
IRES-mCherry (empty vector) MSCV2.2 Segmentation of imaged cells (Fig. 1, 
3, S7, S9, S14); Empty vector control 
(Fig. 2-3, S5, S12, S13, S14) 
p21-IRES-mCherry MSCV2.2 Induction of cell-cycle lengthening 
(Fig. 2B) 
p27-IRES-mCherry MSCV2.2 Induction of cell-cycle lengthening 
(Fig. 2B) 
PU.1-IRES-mCherry  MSCV2.2 Test for PU.1 positive feedback 
regulation (Fig. 3, S5, S13) 
PU.1-ets-IRES-mCherry MSCV2.2 Test for role of high PU.1 in 
mediating myeloid differentiation by 
cell-cycle lengthening (Fig. 2C-D);  
Test for role of transcriptional 
positive feedback in PU.1 down-
regulation (Fig. S12) 
IRES-H2B-mCerulean (empty vector) MSCV2.2 Empty vector control (Fig. S10). 
Color chosen to minimize 
interference with Alexa-647 ?PU.1 
antibody used for 
immunofluorescence staining 
p21-IRES-H2B-mCerulean MSCV2.2 Induction of cell-cycle lengthening, 
PU.1 immunofluorescence staining 
(Fig. S10) 
p27-IRES- H2B-mCerulean MSCV2.2 Induction of cell-cycle lengthening, 
PU.1 immunofluorescence staining 
(Fig. S10) 
IRES-GFP (empty vector) LZRS Test of GFP imaging stability (Fig. S8) 
(6) 
 
  
2 
 
Table S3: Cytokines 
Cytokine Concentration Company 
Murine SCF 5 ng/mL Peprotech 
Murine IL-3 0.5 ng/mL (Fig. S2) 
0.1 ng/mL (all others) 
Peprotech 
Human IL-7 5 ng/mL Peprotech 
Human Flt3L 5 ng/mL Peprotech 
Murine M-CSF 0.5 ng/mL (Fig. 1, S4), 
5 ng/mL (Fig. S6) 
Peprotech 
 
  
3 
 
Table S4:  Primers for quantitative RT-PCR 
 Gene Forward Primer Reverse Primer 
?-actin ACA CCC GCC ACC AGT TC TAC AGC CCG GGG AGC AT 
PU.1 (exon3-4) CTC AGT CAC CAG GTT TCC T TCC AAG CCA TCA GCT TCT C 
PU.1 (5’ UTR) GCA GGG GAT CTG ACC AA CGT AAG TAA CCA AGT CAT CCG AT 
Cyclin D2 GCA GGA TGA TGA AGT GAA CAC GAG ACA ATC CAC ATC AGT GTG 
Cdc25a GAA TAA ATT CCC TAC CTC AGA AGC TGT CGT GGT CTA GAG AAT CAG 
Myb GAA GAT GCT ACC TCA GAC C ATT CCA GAT TCA TCC GAT TCC 
Myc CTG TAC CTC GTC CGA TTC C GCT CTT CTT CAG AGT CGC T 
p21 TTG CAC TCT GGT GTC TGA G GTG ATA GAA ATC TGT CAG GCT G 
Gfi1 AAT GCA GCA AGG TGT TCT C CTT ACA GTC AAA GCT GCG T 
 
4 
 
symbol description parameter value
cell-cycle transcriptional hybrid
αm mRNA transcription rate 3 hr
−1vol−1 N/A N/A
α
(1)
m mRNA transcription rate (low) N/A 1.25 hr−1vol−1 0.45 hr−1vol−1
α
(2)
m mRNA transcription rate (high) N/A 3 hr−1vol−1 3 hr−1vol−1
δm mRNA degradation rate 0.3 hr
−1 0.3 hr−1 0.3 hr−1
αp protein translation rate 100 hr
−1 922 hr−1 100 hr−1
δp protein degradation rate 0.02 hr
−1 0.3 hr−1 0.02 hr−1
N Hill coeﬀ. for transcription activation N/A N/A 5
M Hill coeﬀ. for cell-cycle arrest N/A N/A 20
πt threshold for transcription activation N/A 17000 5000
τmin1 minimum G1 duration 2 hr 2 hr 2 hr
τmax1 maximum G1 duration 42 hr 42 hr 42 hr
τ2 S/G2/M duration (ﬁxed) 42 hr 42 hr 42 hr
πc threshold for G1 arrest 17000 17000 17000
V0 nuclear volume 1 vol 1 vol 1 vol
Table S5: Parameters values used for stochastic single-cell simulations of the cell-cycle coupled
feedback loop (Fig. 4A, S15), transcriptional positive feedback loop (Fig. S17) and hybrid positive
feedback loop (Fig. 4B). Rate constants for gene expression are loosely based on a recent global
study of gene expression kinetics in mammalian cells [24]. Furthermore, parameters are chosen to
recapitulate the following observations: 1) PU.1 has a protein half-life of ∼50 hours (Fig. S6),
and this is incorporated into the cell-cycle couple feedback and hybrid feedback models (n.b. the
hypothetical pure transcriptional feedback model has a considerably shorter PU.1 half-life, but this
is necessary for the mathematically-controlled comparison of the two models, as we discuss in the
text). 2) Macrophages have approximately three fold higher PU.1 levels compared to progenitors
(Fig. 1); 3) Fast and slow-dividing cells have cell-cycle lengths of 10 and 50 hours respectively (Fig.
1); 4) For the hybrid feedback loop model, Hill coeﬃcients match the experimentally observed
number of discrete sites of PU.1 occupancy on its own cis-regulatory elements [11]. 5) Additionally,
gene expression kinetic parameters are chosen such that the steady-state number of copies of PU.1
protein is comparable to the number of PU.1 binding sites in the genome (∼ 104/cell), as measured
by deep-sequencing [43].
5
symbol description parameter value
cell-cycle hybrid
A0 protein synthesis rate (no feedback) 1500 hr
−1 N/A
Amin basal protein synthesis rate N/A 165 hr
−1
Amax maximal protein synthesis rate N/A 1500 hr
−1
Cmax maximum cell division rate 0.1 hr
−1 0.1 hr−1
Cmin minimum cell division rate 0.02 hr
−1 0.02 hr−1
Kp PU.1 level for half-maximal transcriptional activation N/A 6000
Kc PU.1 level for half-maximal cell-cycle arrest 20000 20000
M Hill coeﬃcient for transcriptional activation N/A 5
N Hill coeﬃcient for cell-cycle arrest 20 20
D protein degradation rate 0.02 hr−1 0.02 hr−1
Table S6: Parameters values used for phase plane analysis of the cell-cycle coupled feedback loop
and the hybrid feedback loop (Fig. 4C). Parameters are chosen to loosely correspond to those
analyzed in the stochastic single-cell models (Table S5).
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